“For the second time in recent months, a scientific paper published in a peer-reviewed journal has thoroughly rebutted the present Schedule I status of cannabis under US federal law. According to a just published review in the German scientific journal Deutsches Ärzteblatt International, scientific findings from over 100 controlled clinical trials involving either cannabis or its constituents provide ‘clear evidence that cannabinoids are useful for the treatment of various medical conditions.'”
Related posts:
Bitcoin’s Future Foretold By Developer Momentum
Slowing down the surveillance state: a guide to warrantless government spying
Government to Dispose of Radioactive Waste By Putting It In Our Silverware
Rise of Private Security Is Citizen Response to Declining Police Service
The history of the requirement that U.S. citizens use U.S. passports to travel
Chris Martenson: Official Gold Numbers Don’t Add Up
Going Global 2013 - Internationalizing Your Assets - By Casey Research
Father Of Florida Man Connected To Tsarnaev: FBI Killed My Son ‘Execution-Style’
Secret Court Opinion Finding NSA Surveillance Unconstitutional Released
Beware Of All Enterprises That Require New Clothes
Kucinich defends tea party groups against IRS on ‘Fox News Sunday’
Sweden and Norway to add Bitcoin VAT; Norway to implement Bitcoin tax
Is Switzerland Still Open to Americans?
Germany begs Sweden for more coal as renewable energy plan falters
$11 Trillion Increase in Federal Debt in One Year